4527 Stock Overview
Manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rohto Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,791.50 |
| 52 Week High | JP¥3,688.00 |
| 52 Week Low | JP¥2,640.50 |
| Beta | -0.21 |
| 11 Month Change | -20.01% |
| 3 Month Change | -12.35% |
| 1 Year Change | -9.48% |
| 33 Year Change | 64.93% |
| 5 Year Change | 58.83% |
| Change since IPO | 1,209.03% |
Recent News & Updates
Rohto Pharmaceutical Co.,Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 15
Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Shares Could Be 25% Below Their Intrinsic Value Estimate
Nov 07These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Reasonably Well
Oct 20Recent updates
Rohto Pharmaceutical Co.,Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 15Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Shares Could Be 25% Below Their Intrinsic Value Estimate
Nov 07These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Reasonably Well
Oct 20Shareholders Should Be Pleased With Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Price
Oct 06Returns At Rohto PharmaceuticalLtd (TSE:4527) Appear To Be Weighed Down
Sep 22Here's Why Rohto PharmaceuticalLtd (TSE:4527) Has Caught The Eye Of Investors
Aug 25Rohto Pharmaceutical Co.,Ltd. Just Missed EPS By 6.8%: Here's What Analysts Think Will Happen Next
Aug 11Does Rohto PharmaceuticalLtd (TSE:4527) Have A Healthy Balance Sheet?
Jul 11Calculating The Fair Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)
Jun 23Unpleasant Surprises Could Be In Store For Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Shares
Jun 10Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward
May 14These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely
Apr 03Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching
Mar 21Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year
Mar 07Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)
Feb 26Shareholder Returns
| 4527 | JP Personal Products | JP Market | |
|---|---|---|---|
| 7D | -17.8% | -3.7% | -1.8% |
| 1Y | -9.5% | -10.1% | 11.4% |
Return vs Industry: 4527 matched the JP Personal Products industry which returned -10.1% over the past year.
Return vs Market: 4527 underperformed the JP Market which returned 11.4% over the past year.
Price Volatility
| 4527 volatility | |
|---|---|
| 4527 Average Weekly Movement | 6.5% |
| Personal Products Industry Average Movement | 3.7% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in JP Market | 7.7% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 4527's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: 4527's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1899 | 7,259 | Yamada Kunio | www.rohto.co.jp |
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams.
Rohto Pharmaceutical Co.,Ltd. Fundamentals Summary
| 4527 fundamental statistics | |
|---|---|
| Market cap | JP¥617.57b |
| Earnings (TTM) | JP¥27.26b |
| Revenue (TTM) | JP¥282.05b |
23.4x
P/E Ratio2.3x
P/S RatioIs 4527 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4527 income statement (TTM) | |
|---|---|
| Revenue | JP¥282.05b |
| Cost of Revenue | JP¥120.22b |
| Gross Profit | JP¥161.83b |
| Other Expenses | JP¥134.57b |
| Earnings | JP¥27.26b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 119.50 |
| Gross Margin | 57.38% |
| Net Profit Margin | 9.67% |
| Debt/Equity Ratio | 16.8% |
How did 4527 perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield26%
Payout RatioDoes 4527 pay a reliable dividends?
See 4527 dividend history and benchmarks| Rohto PharmaceuticalLtd dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 05 2024 |
| Days until Ex dividend | 54 days |
| Days until Dividend pay date | 15 days |
Does 4527 pay a reliable dividends?
See 4527 dividend history and benchmarks